SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-012572
Filing Date
2023-04-12
Accepted
2023-04-12 16:25:51
Documents
14
Period of Report
2023-04-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gls-20230412.htm   iXBRL 8-K 58554
2 COURTESY COPY OF REG_FD_DISCLOSURE_APR_12 gls-reg_fd_disclosure_apr_12.pdf 8-K 2967577
3 EX-99.1 gls-ex99_1.htm EX-99 534
  Complete submission text file 0000950170-23-012572.txt   4233726

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20230412.xsd EX-101.SCH 2460
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20230412_lab.xml EX-101.LAB 13904
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20230412_pre.xml EX-101.PRE 10225
8 EXTRACTED XBRL INSTANCE DOCUMENT gls-20230412_htm.xml XML 4881
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 23815972
SIC: 2834 Pharmaceutical Preparations